Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An update on familial hypercholesterolaemia.

L Ose1

  • 1Lipid Clinic, Rikshospitalet, Oslo, Norway. leiv.ose@rh.uio.no

Annals of Medicine
|May 26, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Double-Blind Comparison of the Efficacy and Tolerability of Simvastatin and Fluvastatin in Patients with Primary Hypercholesterolaemia.

Clinical drug investigation·2016
Same author

Erratum to Double-blind comparison of the efficacy and tolerability of simvastatin and fluvastatin in patients with primary hypercholesterolaemia.

Clinical drug investigation·2016
Same author

Oxidized LDL level is related to gene expression of tumour necrosis factor super family members in children and young adults with familial hypercholesterolaemia.

Journal of internal medicine·2012
Same author

Paediatric screening for hypercholesterolaemia in Europe.

Archives of disease in childhood·2011
Same author

A multi-centre, randomised, double-blind 14-week extension study examining the long-term safety and efficacy profile of the ezetimibe/simvastatin combination tablet.

International journal of clinical practice·2007
Same author

Enhanced platelet activation in hyperhomocysteinemic individuals.

Journal of thrombosis and haemostasis : JTH·2006

Familial hypercholesterolaemia (FH) is a genetic condition. This review covers FH diagnosis, treatment for adults and children, and family screening, emphasizing government cooperation for better management.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Public Health

Background:

  • Familial hypercholesterolaemia (FH) is an inherited disorder.
  • Early diagnosis and treatment are crucial for managing FH.
  • A recent World Health Organization (WHO) consultation addressed key aspects of FH.

Purpose of the Study:

  • To review a WHO consultation report on Familial Hypercholesterolaemia (FH).
  • To summarize updates on FH diagnosis, treatment, and management strategies.
  • To highlight recommendations for government involvement in FH care.

Main Methods:

  • Review of a World Health Organization (WHO) consultation report.
  • Synthesis of information on molecular basis, diagnostics, and clinical criteria for FH.

Related Experiment Videos

  • Analysis of treatment guidelines for adults and children, including diet and psychosocial factors.

    • Main Results:

    • The WHO report covers molecular basis, DNA diagnosis, and clinical criteria for FH.
    • It details treatment for adults and children, dietary roles, and psychosocial aspects.
    • Recommendations are provided for contacting relatives and for government cooperation.

    Conclusions:

    • The reviewed report offers a comprehensive update on Familial Hypercholesterolaemia (FH).
    • It emphasizes a multi-faceted approach to FH management, including genetic screening and public health initiatives.
    • Government cooperation is essential for effective FH control and prevention programs.